Status:
COMPLETED
Sun Protection Factor Assay
Lead Sponsor:
Bayer
Conditions:
Sunscreening Agent
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
To evaluate the Sun Protection Factor efficacy on human skin.
Eligibility Criteria
Inclusion
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
- Male and female
- Aged between 18-70 years old.
- Good health as determined from the HRL SHF(Self History Form)
- Signed and dated Informed Consent Form
- Signed and dated HIPAA (Health Insurance Portability and Accountability Act) Form
- An unbAmbiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose)
Exclusion
- Subjects on test at any other research laboratory or clinic.
- Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
- Pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
- Pre-existing other medical conditions (e.g. adult asthma. diabetes).
- Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
- Treatment with antibiotics within two weeks prior to initiation of the test.
- Chronic medication which could affect the results of the study.
- Known pregnant or nursing women.
Key Trial Info
Start Date :
October 29 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 5 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02803021
Start Date
October 29 2015
End Date
November 5 2015
Last Update
December 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union, New Jersey, United States, 07083